What Are the Challenges in Developing Nanotechnology-Based Smart Drugs?
Despite the promising potential, there are several challenges in developing nanotechnology-based smart drugs:
Toxicity: Some nanoparticles may pose toxicity risks, and their long-term effects need thorough investigation. Regulatory Hurdles: The regulatory landscape for nanotechnology-based drugs is still evolving, and gaining approval can be complex. Manufacturing: Producing nanoparticles consistently and at scale can be challenging. Stability: Ensuring the stability of nanoparticles during storage and in the biological environment is crucial for their effectiveness.
